drugset / Trial / NCT01222091

Study on the Effect of a Beta Blocker on Increased Sensitivity to Pain in Humans Caused by Opioids

NCT01222091

Phase 2 Completed 10 enrolled Stanford University
RandomizedCrossoverTriple-blindTreatment

Summary

This research study explores whether a beta-blocker (propranolol) can prevent a person from becoming more sensitive to pain after administration of an opioid (remifentanil). Beta blockers inhibit the sympathetic (fight or flight) response and are often used to treat angina and high blood pressure. In a previous study in human volunteers, the investigators demonstrated an increased sensitivity to pain after a 60-minute infusion of the opioid remifentanil. The goal of this study is to identify a possible inhibitor of this phenomenon.

Timeline

Start
2009-02
Primary completion
2011-05
Completion
2011-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propranolol Small molecule 15 ng/ml Intravenous
Comparator Remifentanil Small molecule 3 ng/ml Intravenous

Indications

No indication recorded.